David A. Largaespada
Gründer bei B-MoGen Biotechnologies, Inc.
Profil
David A.
Largaespada is the founder of three companies.
In 2000, he founded Discovery Genomics, Inc. In 2015, he founded B-MoGen Biotechnologies, Inc. where he also holds the title of Director.
In 2019, he founded Luminary Therapeutics, Inc. where he holds the title of Chairman.
Currently, Dr. Largaespada holds the position of Director at Recombinetics, Inc. and Makana Therapeutics, Inc.
Aktive Positionen von David A. Largaespada
| Unternehmen | Position | Beginn |
|---|---|---|
B-MoGen Biotechnologies, Inc.
 B-MoGen Biotechnologies, Inc. BiotechnologyHealth Technology B-MoGen Biotechnologies, Inc. provides gene editing solutions for antibody validation, human disease research, gene transfer, and mitochondrial DNA editing. It offers custom vector generation services that include multi-gene expression vectors that are delivered via the proven sleeping beauty transposon system; and custom gene targeting vectors. The company was founded by David A. Largaespada and Branden S. Moriarity in 2015 and is headquartered in Minneapolis, MN. | Gründer | 01.01.2015 |
Luminary Therapeutics, Inc.
 Luminary Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Luminary Therapeutics, Inc. provides biotechnology services. The company was founded by Jeff Liter, David Largaespada, Beau Webber and Branden Moriarity in 2019 and is headquartered in Minneapolis, MN. | Gründer | 01.01.2019 |
Recombinetics, Inc.
 Recombinetics, Inc. Packaged SoftwareTechnology Services Recombinetics, Inc. operates as a gene editing technology company with a platform in therapeutics development. It uses genetic technologies to improve the health of people, animals, and the environment. The firms offers transplantable cells, tissues and organs for patients, accelerating drug, device therapy, and animal health, welfare and sustainability services. Recombinetics was founded by Scott C. Fahrenkrug in 2008 and is headquartered in Eagan, MN. | Direktor/Vorstandsmitglied | - |
Makana Therapeutics, Inc.
 Makana Therapeutics, Inc. BiotechnologyHealth Technology Makana Therapeutics, Inc. engages in human transplantation of cells, tissues and organs. The firm focuses on simplified genetics and optimized pig cloning techniques. The company was founded by Joe Tector in 2009 and is headquartered in Miami, FL. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von David A. Largaespada
| Unternehmen | Position | Ende |
|---|---|---|
Discovery Genomics, Inc.
 Discovery Genomics, Inc. BiotechnologyHealth Technology Discovery Genomics, Inc. provides gene therapy tools to cure diseases. It discover gene functions and deliver safe, long-lasting gene therapy. The firm's products include SB Therapeutics Gene Delivery System and Licenses. The company was founded by R. Scott McIvor, Perry B. Hackett, Stephen C. Ekker, and David A. Largaespada in 2000 and is headquartered in Minneapolis, MN. | Gründer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Discovery Genomics, Inc.
Discovery Genomics, Inc. BiotechnologyHealth Technology Discovery Genomics, Inc. provides gene therapy tools to cure diseases. It discover gene functions and deliver safe, long-lasting gene therapy. The firm's products include SB Therapeutics Gene Delivery System and Licenses. The company was founded by R. Scott McIvor, Perry B. Hackett, Stephen C. Ekker, and David A. Largaespada in 2000 and is headquartered in Minneapolis, MN. | Health Technology |
B-MoGen Biotechnologies, Inc.
B-MoGen Biotechnologies, Inc. BiotechnologyHealth Technology B-MoGen Biotechnologies, Inc. provides gene editing solutions for antibody validation, human disease research, gene transfer, and mitochondrial DNA editing. It offers custom vector generation services that include multi-gene expression vectors that are delivered via the proven sleeping beauty transposon system; and custom gene targeting vectors. The company was founded by David A. Largaespada and Branden S. Moriarity in 2015 and is headquartered in Minneapolis, MN. | Health Technology |
Luminary Therapeutics, Inc.
Luminary Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Luminary Therapeutics, Inc. provides biotechnology services. The company was founded by Jeff Liter, David Largaespada, Beau Webber and Branden Moriarity in 2019 and is headquartered in Minneapolis, MN. | Commercial Services |
Recombinetics, Inc.
Recombinetics, Inc. Packaged SoftwareTechnology Services Recombinetics, Inc. operates as a gene editing technology company with a platform in therapeutics development. It uses genetic technologies to improve the health of people, animals, and the environment. The firms offers transplantable cells, tissues and organs for patients, accelerating drug, device therapy, and animal health, welfare and sustainability services. Recombinetics was founded by Scott C. Fahrenkrug in 2008 and is headquartered in Eagan, MN. | Technology Services |
Makana Therapeutics, Inc.
Makana Therapeutics, Inc. BiotechnologyHealth Technology Makana Therapeutics, Inc. engages in human transplantation of cells, tissues and organs. The firm focuses on simplified genetics and optimized pig cloning techniques. The company was founded by Joe Tector in 2009 and is headquartered in Miami, FL. | Health Technology |